Dette medfører en risiko for, at kvinder er underbehandlede, især kvinder i oral østrogenerstatningsbehandling, mens mænd er overbehandlede.
This means that there is a risk that women, especially those on oral oestrogen replacement are under-treated while men are over-treated.